AT
This startup provides biotech research services focused on mast cell biology to enhance therapeutic options for allergy and inflammatory diseases. By targeting these mediators, the company aims to alleviate the growing global burden of these conditions, enabling patients to maintain healthier lifestyles.
Updated 3 months ago
Funding
$3.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This startup provides biotech research services focused on mast cell biology to enhance therapeutic options for allergy and inflammatory diseases. By targeting these mediators, the company aims to alleviate the growing global burden of these conditions, enabling patients to maintain healthier lifestyles.